Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Express Scripts
Dow
McKinsey
McKesson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Isradipine - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

Drug Prices for isradipine

See drug prices for isradipine

Recent Clinical Trials for isradipine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas at AustinEarly Phase 1
University of RochesterPhase 3
National Institute of Neurological Disorders and Stroke (NINDS)Phase 3

See all isradipine clinical trials

Recent Litigation for isradipine

Identify potential future generic entrants

District Court Litigation
Case NameDate
Purdue Pharma L.P. v. PAR Pharmaceutical, Inc.2013-05-17
Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.2012-11-05
Purdue Pharma LP v. Sandoz Inc.2012-10-10

See all isradipine litigation

Pharmacology for isradipine
Medical Subject Heading (MeSH) Categories for isradipine
Synonyms for isradipine
(-)-Isradipine
(.+/-.)-Isradipine
(+-)-Isradipine
(+)-isradipine
(+/-)-Isradipine
(non-Isotopelabelled)Isradipine-d7
(plusmn)-isradipine
2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.
3-Isopropyl 5-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate #
3-isopropyl 5-methyl 4-(benzo[c][1,2,5]oxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
3-methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(4-benzofurazanyl)-2,6-dimethyl-, methyl 1-methylethyl ester, (+-)-
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(4-benzofurazanyl)-2,6-dimethyl-,methyl 1-methylethyl ester, (+-)-
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester (9CI)
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (.+/-.)-
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (+-)-
4-(2,1,3-Benzooxadiazol-4-yl)-2.6-dimethyl-1,4-dihydro-3-isopropyloxycarbonylpyridine-5-carboxylic Acid Methyl Ester
4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid methyl 1-methylethyl ester
4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methhylethyl ester
4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
4-(4-Benzofurazanyl)-1,4-dihydro-2,-6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
695I931
75695-93-1
88977-22-4
AB00514007
AB00514007_02
AB00514007_03
AB2000202
AC-8539
AC1L1GPE
AC1Q426L
ACM131970213
ACT02697
AKOS015895129
AN-7921
AOB5974
API0003052
BCP06719
BDBM50436176
Benzo[1,2,5]oxadiazol-4-aldehyde
BG0371
BPBio1_001323
BRD-A90799790-001-03-3
BRD-A90799790-001-10-8
BSPBio_001201
C19H21N3O5
CAS-75695-93-1
CCG-101027
CCG-213711
CHEBI:6073
CHEMBL1648
CHEMBL315436
CHEMBL3211306
CI0041
Clivoten
CPD002529690
CS-2201
CTK8G0407
D00349
DB00270
DSSTox_CID_3179
DSSTox_GSID_23179
DSSTox_RID_76907
DTXSID4023179
DynaCirc
DynaCirc (TN)
Dynacirc CR
DynaCirc;Prescal;PN-200-110;Clivoten;Esradin;Dynacirc
DynaCire
DynaCire CR
Dynacrine
Esradin
FT-0627542
GTPL4488
HMJIYCCIJYRONP-UHFFFAOYSA-N
HMS1571M03
HMS2051J12
HMS2098M03
HMS2235O12
HMS3268D21
HMS3393J12
HMS3655C17
HMS3715M03
HS-0085
HY-B0233
I06-0364
I0876
Icaz
isopropyl 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridinecarboxylate
Isopropyl methyl (.+/-.)-4-(4-benzfurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
Isopropyl methyl (.+/-.)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
Isopropyl methyl (+-)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
Isopropyl Methyl 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimet
Isopropyl Methyl 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
Isradipin
Isradipine (Dynacirc)
Isradipine (USP/INN)
Isradipine [USAN:INN:BAN]
Isradipine [USAN:USP:INN:BAN]
Isradipine, (+-)-Isomer
Isradipine, >=98% (HPLC), solid
Isradipine, European Pharmacopoeia (EP) Reference Standard
Isradipine, United States Pharmacopeia (USP) Reference Standard
Isradipine(Dynacirc)
Isradipino
Isradipino [Spanish]
Isradipinum
Isradipinum [Latin]
Isrodipine
J-513454
K297
KBio2_000698
KBio2_003266
KBio2_005834
KBioSS_000698
KS-0000118G
Lomir
LS-131190
LS-177211
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
MFCD00153820
MLS000759425
MLS001424076
MLS002154106
MLS003915633
MLS006010138
MolPort-003-848-292
NC00277
NCGC00016931-01
NCGC00025341-01
NCGC00025341-02
NCGC00025341-03
NCGC00025341-06
NSC-759892
NSC759892
O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Pharmakon1600-02300234
PN 200
PN 200-110
PN 205-033
PN 205-034
PN-200-110
PN-200110
PN-205-033
PN-205-034
Prescal
Prestwick0_001021
Prestwick1_001021
Prestwick2_001021
Prestwick3_001021
Rebriden
RL04885
s1662
SAM001246584
SC-16999
SCHEMBL34555
SMR000466320
SMR002529690
SPBio_003062
Spectrum_000218
SR-01000597526
SR-01000597526-1
SR-01000597526-2
SW220017-1
Tox21_110690
Tox21_110690_1
VA11116

US Patents and Regulatory Information for isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan ISRADIPINE isradipine TABLET, EXTENDED RELEASE;ORAL 201067-002 Nov 27, 2015 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-002 Jan 5, 2006 AB RX No Yes   Start Trial   Start Trial   Start Trial
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-002 Apr 24, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-002 Dec 20, 1990 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994   Start Trial   Start Trial
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990   Start Trial   Start Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994   Start Trial   Start Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994   Start Trial   Start Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
McKinsey
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.